Chief Scientific Officer John Renger sold $2.2M of Cerevel Therapeutics Holdings, Inc.

Sold$2,227,624

$40.50Price

55,000Shares

−95%Stake

What CERE did after the filing

Prices for CERE after this filing aren't in yet.

Traded Wed, Aug 10. Filed Fri, Aug 12, 12:15 PM ET, during the session. Not investment advice.